Maximum Security Anticavity Toothpaste Sachets Recalled for CGMP Deviations
KENIL HEALTHCARE PRIVATE LIMITED is recalling Maximum Security Anticavity Gel Toothpaste sachets distributed in Delaware and North Carolina due to Current Good Manufacturing Practice (CGMP) deviations identified by the FDA.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is FDA Class II with no reported illnesses or injuries. CGMP deviations are manufacturing-process defects rather than known contamination or high-risk pathogens, falling within the Moderate category as a precautionary manufacturing-compliance issue.
Plain-English summary
Maximum Security Anticavity Gel Toothpaste (Sodium Fluoride 0.22%, Fresh Mint Flavor, 0.15 oz sachets, NDC 53247-132-01) manufactured by KENIL HEALTHCARE PRIVATE LIMITED and distributed by Bob Barker Co. Inc. is being recalled. The recall affects approximately 1,559,000 sachets with specific lot numbers and expiration dates: Lot B0010 and B0017 (Exp. 05/31/2026); Lot B0028, B0029, and B0030 (Exp. 06/30/2026); Lot B0052 (Exp. 07/31/2026); and Lot B0091 (Exp. 09/30/2026).
The recall was initiated by the manufacturer on April 24, 2025, and classified by the FDA on May 19, 2025, as a Class II recall. The reason for recall is Current Good Manufacturing Practice (CGMP) deviations. The product was distributed in Delaware and North Carolina.
This is a voluntary recall initiated by the firm. Consumers who have this toothpaste should discontinue use and dispose of it safely. The recall was terminated on February 19, 2026.
The recalled product
- Product
- Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 0.15 OZ (4.25 g) Sachets, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-01
- Manufacturer
- KENIL HEALTHCARE PRIVATE LIMITED
- Category
- Drug — Toothpaste / Oral Care
- Hazard
- Affected units
- 1,559,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot B0010
- B0017
- Exp Date: 05/31/2026
- Lot B0028
- B0029
- B0030
- Exp Date: 06/30/2026
- Lot B0052
- Exp Date: 07/31/2026
- Lot B0091
- Exp Date: 09/30/2026
Distribution
Part of a larger recall action
This product is one of 20 recalled by KENIL HEALTHCARE PRIVATE LIMITED under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · KENIL HEALTHCARE PRIVATE LIMITED
See all →- ModerateNature Mint Anticavity Fluoride Toothpaste Recall CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateMaximum Security Anticavity Gel Toothpaste recalled for CGMP deviations
FDA (Drugs) · 2025-05-28
- ModerateNature Mint Anticavity Fluoride Toothpaste Recall Due to CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateRapidol Hydrocortisone 1% Anti-Itch Cream Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateNature Mint Anticavity Fluoride Toothpaste Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19